Stay updated on REGN668 Safety in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the REGN668 Safety in Atopic Dermatitis Clinical Trial page.

Latest updates to the REGN668 Safety in Atopic Dermatitis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedLocations section reorganized to list participating sites by state (CA, FL, IL, MI, NY, OR, PA, TX) and the revision version updated to v3.3.3.SummaryDifference1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedFooter revision updated from v3.3.1 to v3.3.2. No study details or page functionality appear affected.SummaryDifference0.1%

- Check37 days agoChange DetectedPublications section wording updated to indicate automatic population from PubMed and page revision to v3.3.1; the previous PubMed text and Revision: v3.2.0 were replaced.SummaryDifference0.1%

- Check44 days agoChange DetectedThe government funding/operational status notice banner has been removed. This banner previously informed users about potential delays in updates.SummaryDifference0.4%

- Check58 days agoChange DetectedNo significant changes detected; any differences are minor UI adjustments that do not affect core study information such as eligibility, study design, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check87 days agoChange DetectedCore content updated to include a government funding lapse notice and operating-status guidance; version updated to v3.2.0.SummaryDifference5%

Stay in the know with updates to REGN668 Safety in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REGN668 Safety in Atopic Dermatitis Clinical Trial page.